{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T14:28:03Z","timestamp":1769264883638,"version":"3.49.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Systemic sclerosis (SSc; scleroderma) is a complicated idiopathic connective tissue disease with seldom effective treatment. GUI-ZHI-FU-LING-WAN (GFW) is a classic Traditional Chinese Medicine (TCM) formula widely used for the treatment of SSc. However, the mechanism of how the GFW affects SSc remains unclear. In this study, the system biology approach was utilized to analyze herb compounds and related targets to get the general information of GFW. The KEGG enrichment analysis of 1645 related targets suggested that the formula is involved in the VEGF signaling pathway, the Toll-like receptor signaling pathway, etc. Quantitative and qualitative analysis of the relationship among the 3 subsets (formula targets, drug targets and disease genes) showed that the formula targets overlapped with 38.0% drug targets and 26.0% proteins encoded by disease genes. Through the analysis of SSc related microarray statistics from the GEO database, we also validated the consistent expression behavior among the 3 subsets before and after treatment. To further reveal the mechanism of prescription, we constructed a network among 3 subsets and decomposed it into 24 modules to decipher how GFW interfere in the progress of SSc. The modules indicated that the intervention may come into effect through following pathogenic processes: vasculopathy, immune dysregulation and tissue fibrosis. Vitro experiments confirmed that GFW could suppress the proliferation of fibroblasts and decrease the Th1 cytokine (TNF-\u03b1, MIP-2 and IL-6) expression for lipopolysaccharide (LPS) and bleomycin (BLM) stimulation in macrophages, which is consistent with previous conclusion that GFW is able to relieve SSc. The systems biology approach provides a new insight for deepening understanding about TCM.<\/jats:p>","DOI":"10.1038\/s41598-018-36314-2","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T11:32:59Z","timestamp":1548243179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Deciphering the Potential Pharmaceutical Mechanism of GUI-ZHI-FU-LING-WAN on Systemic Sclerosis based on Systems Biology Approaches"],"prefix":"10.1038","volume":"9","author":[{"given":"Qiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoshan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feilong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duoli","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengping","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,23]]},"reference":[{"key":"36314_CR1","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F Van den Hoogen","year":"2013","unstructured":"Van den Hoogen, F. et al. classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 72, 1747\u20131755, https:\/\/doi.org\/10.1136\/annrheumdis-2013-204424 (2013).","journal-title":"Ann Rheum Dis"},{"key":"36314_CR2","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","volume":"6","author":"D Pattanaik","year":"2015","unstructured":"Pattanaik, D., Brown, M., Postlethwaite, B. C. & Postlethwaite, A. E. Pathogenesis of Systemic Sclerosis. Front Immunol 6, 272, https:\/\/doi.org\/10.3389\/fimmu.2015.00272 (2015).","journal-title":"Front Immunol"},{"key":"36314_CR3","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/ard.2008.096677","volume":"68","author":"O Kowal-Bielecka","year":"2009","unstructured":"Kowal-Bielecka, O. et al. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis 68, 620\u2013628, https:\/\/doi.org\/10.1136\/ard.2008.096677 (2009).","journal-title":"Ann Rheum Dis"},{"key":"36314_CR4","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/rheumatology\/ker271","volume":"51","author":"L Guillevin","year":"2012","unstructured":"Guillevin, L. et al. Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls. Rheumatology (Oxford) 51, 460\u2013467, https:\/\/doi.org\/10.1093\/rheumatology\/ker271 (2012).","journal-title":"Rheumatology (Oxford)"},{"key":"36314_CR5","doi-asserted-by":"publisher","unstructured":"Pellar, R. E. & Pope, J. E. Evidence-based management of systemic sclerosis: Navigating recommendations and guidelines. Semin Arthritis Rheum, https:\/\/doi.org\/10.1016\/j.semarthrit.2016.12.003 (2016).","DOI":"10.1016\/j.semarthrit.2016.12.003"},{"key":"36314_CR6","doi-asserted-by":"publisher","unstructured":"Writing Group of Recommendations of Expert Panel from Chinese Geriatrics Society on the Clinical Use of Compound Danshen Dripping, P. Recommendations on the Clinical Use of Compound Danshen Dripping Pills. Chin Med J (Engl) 130, 972\u2013978, https:\/\/doi.org\/10.4103\/0366-6999.204106 (2017).","DOI":"10.4103\/0366-6999.204106"},{"key":"36314_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3109\/13697137.2013.876618","volume":"17","author":"C Hu","year":"2014","unstructured":"Hu, C. et al. Guizhi fuling capsule, an ancient Chinese formula, attenuates endometriosis in rats via induction of apoptosis. Climacteric 17, 410\u2013416, https:\/\/doi.org\/10.3109\/13697137.2013.876618 (2014).","journal-title":"Climacteric"},{"key":"36314_CR8","first-page":"78","volume":"25","author":"H Cao","year":"2003","unstructured":"Cao, H. The study and application of GUI-ZHI-FU-LING-WAN in Japan. Foreign Med (Chin Med) 25, 78\u201381 (2003).","journal-title":"Foreign Med (Chin Med)"},{"key":"36314_CR9","doi-asserted-by":"publisher","first-page":"804298","DOI":"10.1155\/2010\/804298","volume":"2010","author":"Y Yoshihisa","year":"2010","unstructured":"Yoshihisa, Y. et al. The traditional Japanese formula keishibukuryogan inhibits the production of inflammatory cytokines by dermal endothelial cells. Mediators Inflamm 2010, 804298, https:\/\/doi.org\/10.1155\/2010\/804298 (2010).","journal-title":"Mediators Inflamm"},{"key":"36314_CR10","first-page":"1","volume":"55","author":"M Inokawa","year":"2006","unstructured":"Inokawa, M., Iguchi, K. & Kohda, H. Thermographic evaluation of the efficacy of Kampo medicines. Hiroshima J Med Sci 55, 1\u20138 (2006).","journal-title":"Hiroshima J Med Sci"},{"key":"36314_CR11","doi-asserted-by":"publisher","first-page":"359282","DOI":"10.1155\/2012\/359282","volume":"2012","author":"Y Nagata","year":"2012","unstructured":"Nagata, Y. et al. Effect of keishibukuryogan on endothelial function in patients with at least one component of the diagnostic criteria for metabolic syndrome: a controlled clinical trial with crossover design. Evid Based Complement Alternat Med 2012, 359282, https:\/\/doi.org\/10.1155\/2012\/359282 (2012).","journal-title":"Evid Based Complement Alternat Med"},{"key":"36314_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/VHRM.S15429","volume":"7","author":"YL Xue","year":"2011","unstructured":"Xue, Y. L., Shi, H. X., Murad, F. & Bian, K. Vasodilatory effects of cinnamaldehyde and its mechanism of action in the rat aorta. Vasc Health Risk Manag 7, 273\u2013280, https:\/\/doi.org\/10.2147\/VHRM.S15429 (2011).","journal-title":"Vasc Health Risk Manag"},{"key":"36314_CR13","doi-asserted-by":"publisher","first-page":"3620130","DOI":"10.1155\/2017\/3620130","volume":"2017","author":"T Tomita","year":"2017","unstructured":"Tomita, T., Hirayama, A., Matsui, H. & Aoyagi, K. Effect of Keishibukuryogan, a Japanese Traditional Kampo Prescription, on Improvement of Microcirculation and Oketsu and Induction of Endothelial Nitric Oxide: A Live Imaging Study. Evid Based Complement Alternat Med 2017, 3620130, https:\/\/doi.org\/10.1155\/2017\/3620130 (2017).","journal-title":"Evid Based Complement Alternat Med"},{"key":"36314_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jep.2011.11.016","volume":"139","author":"L Liu","year":"2012","unstructured":"Liu, L. et al. Taoren-Honghua herb pair and its main components promoting blood circulation through influencing on hemorheology, plasma coagulation and platelet aggregation. J Ethnopharmacol 139, 381\u2013387, https:\/\/doi.org\/10.1016\/j.jep.2011.11.016 (2012).","journal-title":"J Ethnopharmacol"},{"key":"36314_CR15","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s10753-015-0265-3","volume":"39","author":"X Jin","year":"2016","unstructured":"Jin, X. et al. Anti-inflammatory and Anti-oxidative Activities of Paeonol and Its Metabolites Through Blocking MAPK\/ERK\/p38 Signaling Pathway. Inflammation 39, 434\u2013446, https:\/\/doi.org\/10.1007\/s10753-015-0265-3 (2016).","journal-title":"Inflammation"},{"key":"36314_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jep.2016.12.042","volume":"198","author":"LC Li","year":"2017","unstructured":"Li, L. C. & Kan, L. D. Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects. J Ethnopharmacol 198, 45\u201363, https:\/\/doi.org\/10.1016\/j.jep.2016.12.042 (2017).","journal-title":"J Ethnopharmacol"},{"key":"36314_CR17","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.bbrc.2014.01.151","volume":"445","author":"C Pastrello","year":"2014","unstructured":"Pastrello, C. et al. Integration, visualization and analysis of human interactome. Biochem Biophys Res Commun 445, 757\u2013773, https:\/\/doi.org\/10.1016\/j.bbrc.2014.01.151 (2014).","journal-title":"Biochem Biophys Res Commun"},{"key":"36314_CR18","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1101\/gad.1528707","volume":"21","author":"X Zhu","year":"2007","unstructured":"Zhu, X., Gerstein, M. & Snyder, M. Getting connected: analysis and principles of biological networks. Genes Dev 21, 1010\u20131024, https:\/\/doi.org\/10.1101\/gad.1528707 (2007).","journal-title":"Genes Dev"},{"key":"36314_CR19","doi-asserted-by":"publisher","first-page":"D1089","DOI":"10.1093\/nar\/gks1100","volume":"41","author":"R Xue","year":"2013","unstructured":"Xue, R. et al. TCMID: Traditional Chinese Medicine integrative database for herb molecular mechanism analysis. Nucleic Acids Res 41, D1089\u20131095, https:\/\/doi.org\/10.1093\/nar\/gks1100 (2013).","journal-title":"Nucleic Acids Res"},{"key":"36314_CR20","doi-asserted-by":"publisher","first-page":"D369","DOI":"10.1093\/nar\/gkw1102","volume":"45","author":"A Chatr-Aryamontri","year":"2017","unstructured":"Chatr-Aryamontri, A. et al. The BioGRID interaction database: 2017 update. Nucleic Acids Res 45, D369\u2013D379, https:\/\/doi.org\/10.1093\/nar\/gkw1102 (2017).","journal-title":"Nucleic Acids Res"},{"key":"36314_CR21","doi-asserted-by":"publisher","first-page":"1.2.1","DOI":"10.1002\/cpbi.27","volume":"58","author":"JS Amberger","year":"2017","unstructured":"Amberger, J. S. & Hamosh, A. Searching Online Mendelian Inheritance in Man (OMIM): A Knowledgebase of Human Genes and Genetic Phenotypes. Curr Protoc Bioinformatics 58, 1.2.1\u20131.2.12, https:\/\/doi.org\/10.1002\/cpbi.27 (2017).","journal-title":"Curr Protoc Bioinformatics"},{"key":"36314_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep22602","volume":"6","author":"L Huang","year":"2016","unstructured":"Huang, L., Lv, Q., Xie, D., Shi, T. & Wen, C. Deciphering the Potential Pharmaceutical Mechanism of Chinese Traditional Medicine (Gui-Zhi-Shao-Yao-Zhi-Mu) on Rheumatoid Arthritis. Sci Rep 6, 22602, https:\/\/doi.org\/10.1038\/srep22602 (2016).","journal-title":"Sci Rep"},{"key":"36314_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep16401","volume":"5","author":"L Huang","year":"2015","unstructured":"Huang, L., Lv, Q., Liu, F., Shi, T. & Wen, C. A Systems Biology-Based Investigation into the Pharmacological Mechanisms of Sheng-ma-bie-jia-tang Acting on Systemic Lupus Erythematosus by Multi-Level Data Integration. Sci Rep 5, 16401, https:\/\/doi.org\/10.1038\/srep16401 (2015).","journal-title":"Sci Rep"},{"key":"36314_CR24","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.jep.2016.10.064","volume":"194","author":"L Sun","year":"2016","unstructured":"Sun, L. et al. The essential oil from the twigs of Cinnamomum cassia Presl alleviates pain and inflammation in mice. J Ethnopharmacol 194, 904\u2013912, https:\/\/doi.org\/10.1016\/j.jep.2016.10.064 (2016).","journal-title":"J Ethnopharmacol"},{"key":"36314_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ijbiomac.2014.04.010","volume":"68","author":"Y Sun","year":"2014","unstructured":"Sun, Y. Biological activities and potential health benefits of polysaccharides from Poria cocos and their derivatives. Int J Biol Macromol 68, 131\u2013134, https:\/\/doi.org\/10.1016\/j.ijbiomac.2014.04.010 (2014).","journal-title":"Int J Biol Macromol"},{"key":"36314_CR26","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1080\/14786419.2011.568942","volume":"25","author":"NY Yang","year":"2011","unstructured":"Yang, N. Y., Liu, L., Tao, W. W., Duan, J. A., Liu, X. H. & Huang, S. P. Antithrombotic lipids from Semen Persicae. Nat Prod Res 25, 1650\u20131656, https:\/\/doi.org\/10.1080\/14786419.2011.568942 (2011).","journal-title":"Nat Prod Res"},{"key":"36314_CR27","doi-asserted-by":"publisher","first-page":"9475074","DOI":"10.1155\/2017\/9475074","volume":"2017","author":"P Xie","year":"2017","unstructured":"Xie, P., Cui, L., Shan, Y. & Kang, W. Y. Antithrombotic Effect and Mechanism of Radix Paeoniae Rubra. Biomed Res Int 2017, 9475074, https:\/\/doi.org\/10.1155\/2017\/9475074 (2017).","journal-title":"Biomed Res Int"},{"key":"36314_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fphar.2011.00010","volume":"2","author":"DY He","year":"2011","unstructured":"He, D. Y. & Dai, S. M. Anti-inflammatory and immunomodulatory effects of paeonia lactiflora pall., a traditional chinese herbal medicine. Front Pharmacol 2, 10, https:\/\/doi.org\/10.3389\/fphar.2011.00010 (2011).","journal-title":"Front Pharmacol"},{"key":"36314_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fphys.2017.00193","volume":"8","author":"MH Liu","year":"2017","unstructured":"Liu, M. H. et al. Prevention of Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice by Paeonol. Front Physiol 8, 193, https:\/\/doi.org\/10.3389\/fphys.2017.00193 (2017).","journal-title":"Front Physiol"},{"key":"36314_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jphs.2015.12.007","volume":"130","author":"T Zhai","year":"2016","unstructured":"Zhai, T. et al. Unique immunomodulatory effect of paeoniflorin on type I and II macrophages activities. J Pharmacol Sci 130, 143\u2013150, https:\/\/doi.org\/10.1016\/j.jphs.2015.12.007 (2016).","journal-title":"J Pharmacol Sci"},{"issue":"3","key":"36314_CR31","first-page":"266","volume":"23","author":"F Gaillard-Bigot","year":"2016","unstructured":"Gaillard-Bigot, F. et al. Treprostinil iontophoresis improves digital blood flow during local cooling in systemic sclerosis. Fund Clin Pharmacol 23(3), 266\u2013270 (2016).","journal-title":"Fund Clin Pharmacol"},{"key":"36314_CR32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/1472-6882-14-363","volume":"14","author":"KS Kim","year":"2014","unstructured":"Kim, K. S. et al. Effects of beta-sitosterol derived from Artemisia capillaris on the activated human hepatic stellate cells and dimethylnitrosamine-induced mouse liver fibrosis. BMC Complement Altern Med 14, 363, https:\/\/doi.org\/10.1186\/1472-6882-14-363 (2014).","journal-title":"BMC Complement Altern Med"},{"key":"36314_CR33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1054\/plef.2001.0273","volume":"64","author":"AB Awad","year":"2001","unstructured":"Awad, A. B., Smith, A. J. & Fink, C. S. Plant sterols regulate rat vascular smooth muscle cell growth and prostacyclin release in culture. Prostaglandins Leukot Essent Fatty Acids 64, 323\u2013330, https:\/\/doi.org\/10.1054\/plef.2001.0273 (2001).","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"36314_CR34","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/ard.2010.133587","volume":"70","author":"TC Barnes","year":"2011","unstructured":"Barnes, T. C., Spiller, D. G., Anderson, M. E., Edwards, S. W. & Moots, R. J. Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis? Ann Rheum Dis 70, 366\u2013372, https:\/\/doi.org\/10.1136\/ard.2010.133587 (2011).","journal-title":"Ann Rheum Dis"},{"key":"36314_CR35","doi-asserted-by":"publisher","first-page":"R157","DOI":"10.1186\/ar4672","volume":"16","author":"L Desallais","year":"2014","unstructured":"Desallais, L. et al. Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis. Arthritis Res Ther 16, R157, https:\/\/doi.org\/10.1186\/ar4672 (2014).","journal-title":"Arthritis Res Ther"},{"key":"36314_CR36","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.biopha.2016.12.080","volume":"87","author":"B Zhou","year":"2017","unstructured":"Zhou, B. et al. MicroRNA-202-3p regulates scleroderma fibrosis by targeting matrix metalloproteinase 1. Biomed Pharmacother 87, 412\u2013418, https:\/\/doi.org\/10.1016\/j.biopha.2016.12.080 (2017).","journal-title":"Biomed Pharmacother"},{"key":"36314_CR37","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/labinvest.2017.43","volume":"97","author":"J Lu","year":"2017","unstructured":"Lu, J. et al. Increased expression of latent TGF-beta-binding protein 4 affects the fibrotic process in scleroderma by TGF-beta\/SMAD signaling. Lab Invest 97, 1121, https:\/\/doi.org\/10.1038\/labinvest.2017.43 (2017).","journal-title":"Lab Invest"},{"key":"36314_CR38","doi-asserted-by":"publisher","first-page":"600","DOI":"10.7326\/0003-4819-133-8-200010170-00010","volume":"133","author":"VD Steen","year":"2000","unstructured":"Steen, V. D. & Medsger, T. A. Jr. Long-term outcomes of scleroderma renal crisis. Ann Intern Med 133, 600\u2013603 (2000).","journal-title":"Ann Intern Med"},{"key":"36314_CR39","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11926-015-0560-x","volume":"18","author":"V Sobanski","year":"2016","unstructured":"Sobanski, V., Launay, D., Hachulla, E. & Humbert, M. Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH). Curr Rheumatol Rep 18, 10, https:\/\/doi.org\/10.1007\/s11926-015-0560-x (2016).","journal-title":"Curr Rheumatol Rep"},{"key":"36314_CR40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Galie","year":"2016","unstructured":"Galie, N. et al. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37, 67\u2013119, https:\/\/doi.org\/10.1093\/eurheartj\/ehv317 (2016).","journal-title":"Eur Heart J"},{"key":"36314_CR41","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3109\/14756366.2014.995180","volume":"30","author":"C Kontogiorgis","year":"2015","unstructured":"Kontogiorgis, C. et al. Studies on the antiplatelet and antithrombotic profile of anti-inflammatory coumarin derivatives. J Enzyme Inhib Med Chem 30, 925\u2013933, https:\/\/doi.org\/10.3109\/14756366.2014.995180 (2015).","journal-title":"J Enzyme Inhib Med Chem"},{"key":"36314_CR42","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/exd.13366","volume":"26","author":"M Ide","year":"2017","unstructured":"Ide, M. et al. Transforming growth factor beta-inhibitor Repsox downregulates collagen expression of scleroderma dermal fibroblasts and prevents bleomycin-induced mice skin fibrosis. Exp Dermatol 26, 1139\u20131143, https:\/\/doi.org\/10.1111\/exd.13366 (2017).","journal-title":"Exp Dermatol"},{"key":"36314_CR43","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.biopha.2016.08.011","volume":"83","author":"H Li","year":"2016","unstructured":"Li, H., Yang, L., Zhang, Y. & Gao, Z. Kaempferol inhibits fibroblast collagen synthesis, proliferation and activation in hypertrophic scar via targeting TGF-beta receptor type I. Biomed Pharmacother 83, 967\u2013974, https:\/\/doi.org\/10.1016\/j.biopha.2016.08.011 (2016).","journal-title":"Biomed Pharmacother"},{"key":"36314_CR44","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00403-014-1466-6","volume":"306","author":"A Usategui","year":"2014","unstructured":"Usategui, A., Criado, G., Del Rey, M. J., Fare, R. & Pablos, J. L. Topical vitamin D analogue calcipotriol reduces skin fibrosis in experimental scleroderma. Arch Dermatol Res 306, 757\u2013761, https:\/\/doi.org\/10.1007\/s00403-014-1466-6 (2014).","journal-title":"Arch Dermatol Res"},{"key":"36314_CR45","doi-asserted-by":"publisher","first-page":"e1010983","DOI":"10.1080\/19381980.2015.1010983","volume":"7","author":"M Terao","year":"2015","unstructured":"Terao, M. et al. A vitamin D analog inhibits Th2 cytokine- and TGFbeta -induced periostin production in fibroblasts: a potential role for vitamin D in skin sclerosis. Dermatoendocrinol 7, e1010983, https:\/\/doi.org\/10.1080\/19381980.2015.1010983 (2015).","journal-title":"Dermatoendocrinol"},{"key":"36314_CR46","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s10165-012-0787-6","volume":"23","author":"M Ioannou","year":"2013","unstructured":"Ioannou, M. et al. Upregulation of VEGF expression is associated with accumulation of HIF-1alpha in the skin of naive scleroderma patients. Mod Rheumatol 23, 1245\u20131248, https:\/\/doi.org\/10.1007\/s10165-012-0787-6 (2013).","journal-title":"Mod Rheumatol"},{"key":"36314_CR47","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ijcard.2017.04.024","volume":"241","author":"M Deidda","year":"2017","unstructured":"Deidda, M. et al. Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension. Int J Cardiol 241, 401\u2013406, https:\/\/doi.org\/10.1016\/j.ijcard.2017.04.024 (2017).","journal-title":"Int J Cardiol"},{"key":"36314_CR48","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12079-011-0122-6","volume":"5","author":"A Leask","year":"2011","unstructured":"Leask, A. Possible strategies for anti-fibrotic drug intervention in scleroderma. J Cell Commun Signal 5, 125\u2013129, https:\/\/doi.org\/10.1007\/s12079-011-0122-6 (2011).","journal-title":"J Cell Commun Signal"},{"key":"36314_CR49","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/ard.2010.131243","volume":"70","author":"P Dieude","year":"2011","unstructured":"Dieude, P. et al. NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis. Ann Rheum Dis 70, 668\u2013674, https:\/\/doi.org\/10.1136\/ard.2010.131243 (2011).","journal-title":"Ann Rheum Dis"},{"key":"36314_CR50","first-page":"S46","volume":"29","author":"V Riccieri","year":"2011","unstructured":"Riccieri, V. et al. Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis. Clin Exp Rheumatol 29, S46\u201352 (2011).","journal-title":"Clin Exp Rheumatol"},{"key":"36314_CR51","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13317-016-0077-y","volume":"7","author":"M De Santis","year":"2016","unstructured":"De Santis, M. et al. Nailfold videocapillaroscopy and serum VEGF levels in scleroderma are associated with internal organ involvement. Auto Immun Highlights 7, 5, https:\/\/doi.org\/10.1007\/s13317-016-0077-y (2016).","journal-title":"Auto Immun Highlights"},{"key":"36314_CR52","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ajpath.2012.09.007","volume":"182","author":"S Bhattacharyya","year":"2013","unstructured":"Bhattacharyya, S. et al. Toll-like receptor 4 signaling augments transforming growth factor-beta responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma. Am J Pathol 182, 192\u2013205, https:\/\/doi.org\/10.1016\/j.ajpath.2012.09.007 (2013).","journal-title":"Am J Pathol"},{"key":"36314_CR53","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11926-017-0630-3","volume":"19","author":"C Dowson","year":"2017","unstructured":"Dowson, C., Simpson, N., Duffy, L. & O\u2019Reilly, S. Innate Immunity in Systemic Sclerosis. Curr Rheumatol Rep 19, 2, https:\/\/doi.org\/10.1007\/s11926-017-0630-3 (2017).","journal-title":"Curr Rheumatol Rep"},{"key":"36314_CR54","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cytogfr.2015.12.002","volume":"28","author":"M Liu","year":"2016","unstructured":"Liu, M. et al. New insights into CD4(+) T cell abnormalities in systemic sclerosis. Cytokine Growth Factor Rev 28, 31\u201336, https:\/\/doi.org\/10.1016\/j.cytogfr.2015.12.002 (2016).","journal-title":"Cytokine Growth Factor Rev"},{"key":"36314_CR55","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5493\/wjem.v7.i3.84","volume":"7","author":"E Krasimirova","year":"2017","unstructured":"Krasimirova, E. et al. Treg\/Th17 cell balance and phytohaemagglutinin activation of T lymphocytes in peripheral blood of systemic sclerosis patients. World J Exp Med 7, 84\u201396, https:\/\/doi.org\/10.5493\/wjem.v7.i3.84 (2017).","journal-title":"World J Exp Med"},{"key":"36314_CR56","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.imlet.2017.09.007","volume":"195","author":"C Chizzolini","year":"2018","unstructured":"Chizzolini, C., Dufour, A. M. & Brembilla, N. C. Is there a role for IL-17 in the pathogenesis of systemic sclerosis? Immunol Lett 195, 61\u201367, https:\/\/doi.org\/10.1016\/j.imlet.2017.09.007 (2018).","journal-title":"Immunol Lett"},{"key":"36314_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-4-2","volume":"4","author":"GD Bader","year":"2003","unstructured":"Bader, G. D. & Hogue, C. W. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics 4, 2 (2003).","journal-title":"BMC Bioinformatics"},{"key":"36314_CR58","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0002-9440(10)63289-0","volume":"165","author":"G Lakos","year":"2004","unstructured":"Lakos, G. et al. Targeted disruption of TGF-beta\/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma. Am J Pathol 165, 203\u2013217 (2004).","journal-title":"Am J Pathol"},{"key":"36314_CR59","doi-asserted-by":"publisher","first-page":"R6","DOI":"10.1186\/ar4432","volume":"16","author":"E Lopez-Isac","year":"2014","unstructured":"Lopez-Isac, E. et al. A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility. Arthritis Res Ther 16, R6, https:\/\/doi.org\/10.1186\/ar4432 (2014).","journal-title":"Arthritis Res Ther"},{"key":"36314_CR60","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1002\/art.33501","volume":"64","author":"J Avouac","year":"2012","unstructured":"Avouac, J. et al. Inhibition of activator protein 1 signaling abrogates transforming growth factor beta-mediated activation of fibroblasts and prevents experimental fibrosis. Arthritis Rheum 64, 1642\u20131652, https:\/\/doi.org\/10.1002\/art.33501 (2012).","journal-title":"Arthritis Rheum"},{"key":"36314_CR61","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1136\/annrheumdis-2014-206214","volume":"75","author":"T Mallano","year":"2016","unstructured":"Mallano, T. et al. Activating transcription factor 3 regulates canonical TGFbeta signalling in systemic sclerosis. Ann Rheum Dis 75, 586\u2013592, https:\/\/doi.org\/10.1136\/annrheumdis-2014-206214 (2016).","journal-title":"Ann Rheum Dis"},{"key":"36314_CR62","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1465-9921-14-80","volume":"14","author":"GE Lindahl","year":"2013","unstructured":"Lindahl, G. E. et al. Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease. Respir Res 14, 80, https:\/\/doi.org\/10.1186\/1465-9921-14-80 (2013).","journal-title":"Respir Res"},{"key":"36314_CR63","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1093\/rheumatology\/kes149","volume":"51","author":"T Odani","year":"2012","unstructured":"Odani, T. et al. Up-regulated expression of HLA-DRB5 transcripts and high frequency of the HLA-DRB5*01:05 allele in scleroderma patients with interstitial lung disease. Rheumatology (Oxford) 51, 1765\u20131774, https:\/\/doi.org\/10.1093\/rheumatology\/kes149 (2012).","journal-title":"Rheumatology (Oxford)"},{"key":"36314_CR64","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaut.2017.05.004","volume":"83","author":"PS Tsou","year":"2017","unstructured":"Tsou, P. S. & Sawalha, A. H. Unfolding the pathogenesis of scleroderma through genomics and epigenomics. J Autoimmun 83, 73\u201394, https:\/\/doi.org\/10.1016\/j.jaut.2017.05.004 (2017).","journal-title":"J Autoimmun"},{"key":"36314_CR65","doi-asserted-by":"publisher","first-page":"e100035","DOI":"10.1371\/journal.pone.0100035","volume":"9","author":"MR Arts","year":"2014","unstructured":"Arts, M. R. et al. Systemic sclerosis immunoglobulin induces growth and a pro-fibrotic state in vascular smooth muscle cells through the epidermal growth factor receptor. PLoS One 9, e100035, https:\/\/doi.org\/10.1371\/journal.pone.0100035 (2014).","journal-title":"PLoS One"},{"key":"36314_CR66","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/BOR.0b013e328358575b","volume":"24","author":"MD Mayes","year":"2012","unstructured":"Mayes, M. D. The genetics of scleroderma: looking into the postgenomic era. Curr Opin Rheumatol 24, 677\u2013684, https:\/\/doi.org\/10.1097\/BOR.0b013e328358575b (2012).","journal-title":"Curr Opin Rheumatol"},{"key":"36314_CR67","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2174\/1874312901408010029","volume":"J8","author":"J Jin","year":"2014","unstructured":"Jin, J., Chou, C., Lima, M., Zhou, D. & Zhou, X. Systemic Sclerosis is a Complex Disease Associated Mainly with Immune Regulatory and InflammatoryGenes. Open Rheumatol J8, 29\u201342, https:\/\/doi.org\/10.2174\/1874312901408010029 (2014).","journal-title":"Open Rheumatol"},{"key":"36314_CR68","first-page":"747","volume":"34","author":"R Meyringer","year":"2007","unstructured":"Meyringer, R. et al. Analysis of gene expression patterns in systemic sclerosis fibroblasts using RNA arbitrarily primed-polymerase chain reaction for differential display. J Rheumatol 34, 747\u2013753 (2007).","journal-title":"J Rheumatol"},{"key":"36314_CR69","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mce.2007.05.019","volume":"275","author":"C Stahn","year":"2007","unstructured":"Stahn, C., Lowenberg, M., Hommes, D. W. & Buttgereit, F. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol 275, 71\u201378, https:\/\/doi.org\/10.1016\/j.mce.2007.05.019 (2007).","journal-title":"Mol Cell Endocrinol"},{"key":"36314_CR70","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1126\/science.1246886","volume":"343","author":"CG Joseph","year":"2014","unstructured":"Joseph, C. G. et al. Association of the autoimmune disease scleroderma with an immunologic response to cancer. Science 343, 152\u2013157, https:\/\/doi.org\/10.1126\/science.1246886 (2014).","journal-title":"Science"},{"key":"36314_CR71","doi-asserted-by":"publisher","first-page":"E7526","DOI":"10.1073\/pnas.1615990113","volume":"113","author":"GJ Xu","year":"2016","unstructured":"Xu, G. J. et al. Systematic autoantigen analysis identifies a distinct subtype of scleroderma with coincident cancer. Proc Natl Acad Sci USA 113, E7526\u2013E7534, https:\/\/doi.org\/10.1073\/pnas.1615990113 (2016).","journal-title":"Proc Natl Acad Sci USA"},{"key":"36314_CR72","first-page":"S31","volume":"33","author":"E Ochoa","year":"2015","unstructured":"Ochoa, E. et al. Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis. Clin Exp Rheumatol 33, S31\u201335 (2015).","journal-title":"Clin Exp Rheumatol"},{"key":"36314_CR73","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.biopha.2018.09.037","volume":"108","author":"C Mo","year":"2018","unstructured":"Mo, C., Zeng, Z., Deng, Q., Ding, Y. & Xiao, R. Imbalance between T helper 17 and regulatory T cell subsets plays a significant role in the pathogenesis of systemic sclerosis. Biomed Pharmacother 108, 177\u2013183, https:\/\/doi.org\/10.1016\/j.biopha.2018.09.037 (2018).","journal-title":"Biomed Pharmacother"},{"key":"36314_CR74","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s41232-017-0047-4","volume":"37","author":"Y Asano","year":"2017","unstructured":"Asano, Y. Recent advances in the treatment of skin involvement in systemic sclerosis. Inflamm Regen 37, 12, https:\/\/doi.org\/10.1186\/s41232-017-0047-4 (2017).","journal-title":"Inflamm Regen"},{"key":"36314_CR75","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s11926-014-0474-z","volume":"17","author":"S Bhattacharyya","year":"2015","unstructured":"Bhattacharyya, S. & Varga, J. Emerging roles of innate immune signaling and toll-like receptors in fibrosis and systemic sclerosis. Curr Rheumatol Rep 17, 474, https:\/\/doi.org\/10.1007\/s11926-014-0474-z (2015).","journal-title":"Curr Rheumatol Rep"},{"key":"36314_CR76","doi-asserted-by":"publisher","unstructured":"Bhattacharyya, S. et al. TLR4-dependent fibroblast activation drives persistent organ fibrosis in skin and lung. JCI Insight 3, https:\/\/doi.org\/10.1172\/jci.insight.98850 (2018).","DOI":"10.1172\/jci.insight.98850"},{"key":"36314_CR77","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.imlet.2017.09.011","volume":"195","author":"S Bhattacharyya","year":"2018","unstructured":"Bhattacharyya, S. & Varga, J. Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapy. Immunol Lett 195, 9\u201317, https:\/\/doi.org\/10.1016\/j.imlet.2017.09.011 (2018).","journal-title":"Immunol Lett"},{"key":"36314_CR78","doi-asserted-by":"publisher","first-page":"R136","DOI":"10.1186\/ar4598","volume":"16","author":"G Stifano","year":"2014","unstructured":"Stifano, G. et al. Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis. Arthritis Res Ther 16, R136, https:\/\/doi.org\/10.1186\/ar4598 (2014).","journal-title":"Arthritis Res Ther"},{"key":"36314_CR79","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1038\/480S82a","volume":"480","author":"F Cheung","year":"2011","unstructured":"Cheung, F. TCM: Made in China. Nature 480, S82\u201383, https:\/\/doi.org\/10.1038\/480S82a (2011).","journal-title":"Nature"},{"key":"36314_CR80","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/aps.2016.36","volume":"37","author":"Y Ji","year":"2016","unstructured":"Ji, Y. et al. Paeoniflorin suppresses TGF-beta mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway. Acta Pharmacol Sin 37, 794\u2013804, https:\/\/doi.org\/10.1038\/aps.2016.36 (2016).","journal-title":"Acta Pharmacol Sin"},{"key":"36314_CR81","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/art.21497","volume":"54","author":"JH Distler","year":"2006","unstructured":"Distler, J. H. et al. Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells. Arthritis Rheum 54, 214\u2013225, https:\/\/doi.org\/10.1002\/art.21497 (2006).","journal-title":"Arthritis Rheum"},{"issue":"Suppl 5","key":"36314_CR82","doi-asserted-by":"publisher","first-page":"v8","DOI":"10.1093\/rheumatology\/ken278","volume":"47","author":"D Abraham","year":"2008","unstructured":"Abraham, D. Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc? Rheumatology (Oxford) 47(Suppl 5), v8\u20139, https:\/\/doi.org\/10.1093\/rheumatology\/ken278 (2008).","journal-title":"Rheumatology (Oxford)"},{"key":"36314_CR83","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1196\/annals.1423.047","volume":"1110","author":"M Cerinic Matucci","year":"2007","unstructured":"Cerinic Matucci, M. et al. Therapeutic challenges for systemic sclerosis: facts and future targets. Ann N Y Acad Sci 1110, 448\u2013454, https:\/\/doi.org\/10.1196\/annals.1423.047 (2007).","journal-title":"Ann N Y Acad Sci"},{"key":"36314_CR84","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/BOR.0000000000000172","volume":"27","author":"A Young","year":"2015","unstructured":"Young, A. & Khanna, D. Systemic sclerosis: a systematic review on therapeutic management from 2011 to 2014. Curr Opin Rheumatol 27, 241\u2013248, https:\/\/doi.org\/10.1097\/BOR.0000000000000172 (2015).","journal-title":"Curr Opin Rheumatol"},{"key":"36314_CR85","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/1346-8138.13026","volume":"43","author":"K Yanaba","year":"2016","unstructured":"Yanaba, K. Strategy for treatment of fibrosis in systemic sclerosis: Present and future. J Dermatol 43, 46\u201355, https:\/\/doi.org\/10.1111\/1346-8138.13026 (2016).","journal-title":"J Dermatol"},{"issue":"Suppl 100","key":"36314_CR86","first-page":"14","volume":"34","author":"L Lei","year":"2016","unstructured":"Lei, L. et al. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis. Clin Exp Rheumatol 34(Suppl 100), 14\u201322 (2016).","journal-title":"Clin Exp Rheumatol"},{"key":"36314_CR87","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.3899\/jrheum.090915","volume":"37","author":"T Hua-Huy","year":"2010","unstructured":"Hua-Huy, T. et al. Increased alveolar concentration of nitric oxide is related to serum-induced lung fibroblast proliferation in patients with systemic sclerosis. J Rheumatol 37, 1680\u20131687, https:\/\/doi.org\/10.3899\/jrheum.090915 (2010).","journal-title":"J Rheumatol"},{"key":"36314_CR88","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1093\/rheumatology\/kew224","volume":"55","author":"CP Denton","year":"2016","unstructured":"Denton, C. P. et al. BSR and BHPR guideline for the treatment of systemic sclerosis. Rheumatology (Oxford) 55, 1906\u20131910, https:\/\/doi.org\/10.1093\/rheumatology\/kew224 (2016).","journal-title":"Rheumatology (Oxford)"},{"key":"36314_CR89","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 45, D353\u2013D361, https:\/\/doi.org\/10.1093\/nar\/gkw1092 (2017).","journal-title":"Nucleic Acids Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36314-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36314-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36314-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T04:53:23Z","timestamp":1671252803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36314-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,23]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["36314"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-36314-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,23]]},"assertion":[{"value":"23 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"355"}}